28.04.2021 12:20:05
|
Integra LifeSciences Q1 Profit Tops Estimates
(RTTNews) - Integra LifeSciences Holdings Corp. (IART) reported first quarter adjusted earnings per share of $0.69, compared to $0.48, prior year. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $0.57, for the quarter. Analysts' estimates typically exclude special items.
The company reported GAAP net income of $45.4 million, or $0.53 per share, compared to $9.2 million, or $0.11 per share, last year.
Reported revenues were $360.1 million, an increase of 1.6% on a reported basis and an increase of 2.9% on an organic basis compared to the prior year. Analysts expected revenue of $349.81 million, for the quarter.
For the second quarter, the company expects revenues to be in a range of $372 million to $378 million, representing reported growth of approximately 44% to 46% and organic growth of 42% to 44%. Adjusted earnings per share are expected to be in a range of $0.63 to $0.67.
The company increased the lower end of its full-year 2021 revenue guidance by $5 million to a revised range of $1.525 billion to $1.535 billion, representing reported growth of 11% to 12% and organic growth of 12% to 13%. The company now projects towards the higher end of its full-year 2021 adjusted earnings per share guidance range of $2.86 to $2.93.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Integra LifeSciences Holdings Corp.mehr Nachrichten
Analysen zu Integra LifeSciences Holdings Corp.mehr Analysen
Aktien in diesem Artikel
Integra LifeSciences Holdings Corp. | 23,00 | -6,50% |
|